Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Moultrie

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
The Lancet. Respiratory Medicine|March 26, 2022
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventionsKeertan Dheda, Tahlia Perumal, Harry Moultrie, et al.
Vaccines|June 27, 2024
COVID-19 Vaccine Uptake and Effectiveness by Time since Vaccination in the Western Cape Province, South Africa: An Observational Cohort Study during 2020-2022Reshma Kassanjee, Mary-Ann Davies, Alexa Heekes, et al.
The Pediatric Infectious Disease Journal|September 16, 2014
Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmissionJane C Lindsey, Michael D Hughes, Avy Violari, et al.
The New England Journal of Medicine|June 22, 2012
Nevirapine versus ritonavir-boosted lopinavir for HIV-infected childrenAvy Violari, Jane C Lindsey, Michael D Hughes, et al.
The Lancet. Infectious Diseases|November 15, 2021
Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal studyNazir Ahmed Ismail, Shaheed Vally Omar, Harry Moultrie, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
COVID-19 vaccine uptake and effectiveness by time since vaccination in the Western Cape province, South Africa: An observational cohort study during 2020-2022Reshma Kassanjee, Mary-Ann Davies, Alexa Heekes, et al.
Plos Medicine|June 21, 2022
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trialSimbarashe Takuva, Azwidhwi Takalani, Ishen Seocharan, et al.
Lancet (London, England)|January 22, 2022
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage studyNicole Wolter, Waasila Jassat, Sibongile Walaza, et al.
Nature Communications|October 4, 2022
Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South AfricaNicole Wolter, Waasila Jassat, Sibongile Walaza, et al.
Lancet (London, England)|March 20, 2022
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation studyLinda-Gail Bekker, Nigel Garrett, Ameena Goga, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The Lancet. Respiratory Medicine|March 26, 2022
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventionsKeertan Dheda, Tahlia Perumal, Harry Moultrie, et al.
Vaccines|June 27, 2024
COVID-19 Vaccine Uptake and Effectiveness by Time since Vaccination in the Western Cape Province, South Africa: An Observational Cohort Study during 2020-2022Reshma Kassanjee, Mary-Ann Davies, Alexa Heekes, et al.
The Pediatric Infectious Disease Journal|September 16, 2014
Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmissionJane C Lindsey, Michael D Hughes, Avy Violari, et al.
The New England Journal of Medicine|June 22, 2012
Nevirapine versus ritonavir-boosted lopinavir for HIV-infected childrenAvy Violari, Jane C Lindsey, Michael D Hughes, et al.
The Lancet. Infectious Diseases|November 15, 2021
Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal studyNazir Ahmed Ismail, Shaheed Vally Omar, Harry Moultrie, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
COVID-19 vaccine uptake and effectiveness by time since vaccination in the Western Cape province, South Africa: An observational cohort study during 2020-2022Reshma Kassanjee, Mary-Ann Davies, Alexa Heekes, et al.
Plos Medicine|June 21, 2022
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trialSimbarashe Takuva, Azwidhwi Takalani, Ishen Seocharan, et al.
Lancet (London, England)|January 22, 2022
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage studyNicole Wolter, Waasila Jassat, Sibongile Walaza, et al.
Nature Communications|October 4, 2022
Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South AfricaNicole Wolter, Waasila Jassat, Sibongile Walaza, et al.
Lancet (London, England)|March 20, 2022
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation studyLinda-Gail Bekker, Nigel Garrett, Ameena Goga, et al.
Pageof 7